DELIVERY ORDER
Active36C24827N0053
Department of Veterans Affairs › 248-NETWORK CONTRACT OFFICE 8 (36C248)
$2.5M
obligated · signed 6 days ago
LENALIDOMIDE
Performance timeline
Start
Oct 1, 2026
End
Sep 30, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Sep 30, 2027
EXELAN PHARMACEUTICALS INC
Contract 36C24827N0053
UEI
FYZXNHSQTMG8
Parent Company
EXELAN PHARMACEUTICALS INC
Capabilities & Certifications
Headquarters Location
Congressional District: 23
Current Obligation
$2,469,522
Base + Exercised Options
$2,469,522
Total Ceiling Value
$2,469,522
Contract Type
FIRM FIXED PRICE
NAICS
PHARMACEUTICAL PREPARATION MANUFACTURING
PSC
DRUGS AND BIOLOGICALS
Place of Performance
Congressional District: 23
Awarding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
248-NETWORK CONTRACT OFFICE 8 (36C248)
Office
Funding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
VETERANS HEALTH ADMINISTRATION
Office
Contract Vehicle
36F79720D0227
FSSDepartment of Veterans Affairs
Award type: MULTIPLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.